BIXT stock

Bioxytran Inc (BIXT) financials · $3.5M cap

Bioxytran Inc (BIXT) $3.5M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$1.8M-$2.2M
Net Income-$2.1M-$2.4M
EPS (Diluted)$-0.02$-0.02
Cached annual balance sheet
LineFY2025FY2024
Total Assets$658.6K$138.7K
Current Assets$513.5K$5.2K
Cash & Equivalents$509.9K$5.2K
Inventory$0$0
PP&E$0$0
Total Liabilities$3.2M$1.9M
Current Liabilities$3.2M$1.9M
Short-term Debt$0$48.0K
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity-$2.6M-$1.8M
Retained Earnings-$21.0M-$18.9M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$526.5K-$55.7K
CapEx$0$0
Investing Cash Flow-$23.1K-$28.2K
Financing Cash Flow$1.1M$63.0K
Dividends Paid$0$0
Net Change in Cash$0$0
Free Cash Flow$0$0

FAQ

What is BIXT P/E and revenue?

Bioxytran Inc (BIXT) $3.5M cap.

What is BIXT revenue?

Bioxytran Inc last cached revenue is $0 (FY2025).

Is BIXT profitable?

Bioxytran Inc last cached net income is -$2.1M.

What are BIXT total assets?

Bioxytran Inc last cached total assets are $658.6K.

What is BIXT free cash flow?

Bioxytran Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.